Semaglutide is a medication that was originally developed to manage type 2 diabetes
Unlike endogenous 7-OH formed in trace amounts and cleared rapidly, these lab-made variants can deliver milligram-level doses directly, bypassing metabolic regulation and dramatically increasing -opioid receptor activation and toxicity risk
According to the data, 10mg tirzepatide led to an average weight loss of 12.8% (28lb) from baseline, while 15mg led to weight loss of 14.7% (32.2lb) and placebo was associated with a 3.3% (7.0lb) weight reduction
The VEGFR2-Akt-eNOS angiogenic cascade increases blood vessel formation by 129-152% in preclinical studies
BECOME AN INSIDER Sign up to become a Fresh Faces Rx Insider and be the first to know about the latest offers, events, and more
The subcutaneous doses give you steady, week-long coverage